Sponsored
Cindy Baksh, ConnectiveRx, discusses pharma's shift from reactive audits to real-time prevention—protecting billions in copay spend while ensuring support reaches the patients who need it most.
Cindy Baksh, ConnectiveRx
Advertisement
Articles by Cindy Baksh, ConnectiveRx
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
CVS Health’s Breakup: A Turning Point for Pharma Supply Chains or a Redistribution of Market Power?
2
The End of the Traditional Launch: How JCA, HTA Evolution and Pricing Pressures Are Driving Continuous Evidence Generation
3
Idle US Capacity Could Anchor Generic Drug Reshoring, APIIC Says
4
When Drug Pricing Collides With Politics
5